CHICAGO, December 02, 2025--(BUSINESS WIRE)--Exelon Corporation (Nasdaq: EXC) announced the pricing of its offering of $900 million aggregate principal amount of its 3.25% convertible senior notes due ...
CAMBRIDGE, Mass., December 11, 2025--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into ...
Exelon Corporation (Nasdaq: EXC) announced the pricing of its offering of $900 million aggregate principal amount of its 3.25% convertible senior notes due 2029 in a private placement under the ...
LIVINGSTON, N.J.--(BUSINESS WIRE)--CoreWeave, Inc. (Nasdaq: CRWV) (“CoreWeave”) announced today the pricing of its private offering of $2.25 billion aggregate principal amount of its 1.75% convertible ...
CoreWeave, Inc. (Nasdaq: CRWV) (“CoreWeave”) announced today the pricing of its private offering of $2.25 billion aggregate principal amount of its 1.75% convertible senior notes due 2031 (the “Notes” ...
The initial conversion price is set at approximately $107.80 per share, representing a 25% premium over CoreWeave’s December 8 closing price of $86.24. Prior to September 1, 2031, the notes will be ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately negotiated exchange agreements with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback